| Adherence tradeoff to multiple preventive therapies and all-cause mortality after acute myocardial infarction MJ Korhonen, JG Robinson, IE Annis, RP Hickson, JS Bell, J Hartikainen, ... Journal of the American College of Cardiology 70 (13), 1543-1554, 2017 | 83 | 2017 |
| Online medical care: the current state of “eVisits” in acute primary care delivery R Hickson, J Talbert, WC Thornbury, NR Perin, AJ Goodin Telemedicine and e-Health 21 (2), 90-96, 2015 | 81 | 2015 |
| Development of a new diabetes medication self-efficacy scale and its association with both reported problems in using diabetes medications and self-reported adherence B Sleath, DM Carpenter, SJ Blalock, SA Davis, RP Hickson, C Lee, ... Patient preference and adherence 10, 1003, 2016 | 39 | 2016 |
| Clinical and economic impact of meropenem resistance in Pseudomonas aeruginosa–infected patients WR Judd, PD Ratliff, RP Hickson, DM Stephens, CA Kennedy American journal of infection control 44 (11), 1275-1279, 2016 | 38 | 2016 |
| Changes in Statin Adherence Following an Acute Myocardial Infarction Among Older Adults: Patient Predictors and the Association With Follow‐Up With Primary Care Providers and … RP Hickson, JG Robinson, IE Annis, LA Killeya‐Jones, MJ Korhonen, ... Journal of the American Heart Association 6 (10), e007106, 2017 | 36 | 2017 |
| Opening the black box of the group‐based trajectory modeling process to analyze medication adherence patterns: An example using real‐world statin adherence data RP Hickson, IE Annis, LA Killeya‐Jones, G Fang Pharmacoepidemiology and Drug Safety 29 (3), 357-362, 2020 | 35 | 2020 |
| Evaluation of a pharmaceutical assessment screening tool to measure patient acuity and prioritise pharmaceutical care in a UK hospital RP Hickson, DT Steinke, C Skitterall, SD Williams European Journal of Hospital Pharmacy 24 (2), 74-79, 2017 | 27 | 2017 |
| It's Not Too Late to Improve Statin Adherence: Association Between Changes in Statin Adherence from Before to After Acute Myocardial Infarction and All‐Cause Mortality RP Hickson, JG Robinson, IE Annis, LA Killeya‐Jones, G Fang Journal of the American Heart Association 8 (7), e011378, 2019 | 22 | 2019 |
| It's Not Too Late to Improve Statin Adherence: Association Between Changes in Statin Adherence from Before to After Acute Myocardial Infarction and All‐Cause Mortality RP Hickson, JG Robinson, IE Annis, LA Killeya‐Jones, G Fang Journal of the American Heart Association 8 (7), e011378, 2019 | 22 | 2019 |
| Evaluation of an alternative extended-infusion piperacillin–tazobactam dosing strategy for the treatment of gram-negative infections EM Winstead, PD Ratliff, RP Hickson, JE Mueller, WR Judd International journal of clinical pharmacy 38, 1087-1093, 2016 | 17 | 2016 |
| Implications of Removing Rosiglitazone’s Black Box Warning and Restricted Access Program on the Uptake of Thiazolidinediones and Dipeptidyl Peptidase-4 Inhibitors Among … RP Hickson, AL Cole, SB Dusetzina Journal of managed care & specialty pharmacy 25 (1), 72-79, 2019 | 13 | 2019 |
| Effect of deintensifying diabetes medications on negative events in older veteran nursing home residents JD Niznik, X Zhao, F Slieanu, MK Mor, SL Aspinall, WF Gellad, M Ersek, ... Diabetes Care 45 (7), 1558-1567, 2022 | 9 | 2022 |
| Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin‐Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute … G Fang, IE Annis, JF Farley, N Mahendraratnam, RP Hickson, T Stürmer, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 38 (1 …, 2018 | 9 | 2018 |
| Comparing Continuous and Binary Group-based Trajectory Modeling Using Statin Medication Adherence Data RP Hickson, IE Annis, LA Killeya-Jones, G Fang Medical Care 59 (11), 997-1005, 2021 | 8 | 2021 |
| Review of methodological challenges in comparing the effectiveness of neoadjuvant chemotherapy versus primary debulking surgery for advanced ovarian cancer in the United States AL Cole, AE Austin, RP Hickson, MS Dixon, EL Barber Cancer epidemiology 55, 8-16, 2018 | 7 | 2018 |
| The electronic medication complete communication (EMC2) study: Rationale and methods for a randomized controlled trial of a strategy to promote medication safety in ambulatory care SC Bailey, MK Paasche-Orlow, WG Adams, SA Brokenshire, RP Hickson, ... Contemporary clinical trials 51, 72-77, 2016 | 3 | 2016 |
| Disparities by sex in P2Y12 inhibitor therapy duration, or differences in the balance of ischaemic-benefit and bleeding-risk clinical outcomes in older women versus comparable … RP Hickson, AM Kucharska-Newton, JE Rodgers, BL Sleath, G Fang BMJ open 11 (12), e050236, 2021 | 1 | 2021 |
| Opening the Black Box of the Trajectory Model-Building Process: An Example Using Real-World Statin Adherence Data RP Hickson, IE Annis, LA Killeya-Jones, G Fang PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 26, 258-258, 2017 | 1 | 2017 |
| Comparing Continuous and Binary Trajectory Modeling: An Example Using Real-World Statin Adherence Data RP Hickson, IE Annis, LA Killeya-Jones, G Fang PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 26, 238-239, 2017 | 1 | 2017 |
| Corrigendum to" The electronic medication complete communication (EMC2) study: Rationale and methods for a randomized controlled trial of a strategy to promote medication … SC Bailey, MK Paasche-Orlow, WG Adams, SA Brokenshire, LA Hedlund, ... Contemporary clinical trials 57, 99, 2017 | 1 | 2017 |
Gang Fang, PharmD, MS, PhDDirector, Global Big Data, RWE & Strategy, JAZZ PharmaceuticalsVerified email at jazzpharma.com
